公开(公告)号：EP4431084A1

公开(公告)日：2024-09-18

申请号：EP23382247.7

申请日：2023-03-16

申请人： Adalvo Limited

发明人： CARRETO CANO, Francisco ,  SANCLIMENS PEREZ DE ROZAS, Gloria ,  STRUSI, Orazio Luca

IPC分类号： A61K9/08 ,  A61K9/00 ,  A61K38/14 ,  A61K47/26 ,  A61P31/04

CPC分类号： A61K9/08 ,  A61P31/04 ,  A61K9/0019 ,  A61K47/26 ,  A61K38/14 ,  A61K45/06

摘要： The present invention relates to a pharmaceutical formulation containing dalbavancin or a pharmaceutically acceptable salt thereof, in a form of an aqueous solution. The novel formulations have a significantly increased stability over known dalbavancin formulations.

公开(公告)号：EP4431083A1

公开(公告)日：2024-09-18

申请号：EP23382249.3

申请日：2023-03-16

申请人： Adalvo Limited

发明人： CARRETO CANO, Francisco ,  SANCLIMENS PEREZ DE ROZAS, Gloria ,  STRUSI, Orazio Luca

IPC分类号： A61K9/00 ,  A61K31/7042 ,  A61K47/40 ,  A61P31/04

CPC分类号： A61K9/0019 ,  A61K47/40 ,  A61P31/04 ,  A61K31/7042

摘要： The present invention relates to a pharmaceutical formulation containing dalbavancin or a pharmaceutically acceptable salt thereof, a cyclodextrin and water. The novel fonnulations have a significantly increased stability over known dalbavancin formulations.